According to research presented by Dr. Karim Gariani from the University of Zurich, three and six weeks of therapy give similar incidences of remission in diabetic foot osteomyelitis. Diabetic foot infections are either bone or soft tissue infections below the malleoli. It is the most common issue that can come …
Read More »The role of long-term exposure to Bisphenol A on insulin resistance in patients with type 2 diabetes
In humans with and without DM, exposure to BPA could interfere with insulin signaling pathways and cause insulin resistance. The burden of diabetes type 2 (T2D) has emerged as one of the leading causes of death worldwide is a significant healthcare concern worldwide. In addition to known risk factors for …
Read More »The association between serum DPP4 levels and cognitive decline in prenatal pregnant women with Gestational diabetes mellitus
Serum DPP4 levels may be associated with cognitive dysfunction in perinatal pregnant women with gestational diabetes mellitus Gestational diabetes mellitus (GDM) occurs in about 7% of all pregnancies, ranging from 1% to 14%, depending on the specific population studied, and the diagnostic test used to assess the presence of gestational …
Read More »Health Disparities among People with Diabetes in America and The Relationship of Race, Economic Status, and Ethnicity in Contributing to Health Inequality
Research results show that race, ethnicity, and socio-economic disparity influence the uptake of GLP-1 RA medication among people with diabetes which suggests that they are critical determinants of health. The issue of diabetes has been a topic for research over a long duration of time. Therefore, research is undertaken to …
Read More »DPP-4 Inhibitors Vs. Sulphonylureas As Add-On to Metformin – Assessing CV Outcomes in Type 2 Diabetes
New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …
Read More »Type 2 Diabetes: The Impact of Vision and Hearing Impairments on CV Risk Outcomes and Mortality
A comprehensive study reveals the importance of ophthalmologic and otologic care in patients with T2DM due to the association of increased risks for cardiovascular events in those with a decline in vision and hearing abilities. It is known that patients with type 2 diabetes mellitus (T2DM) have an increased risk …
Read More »Pioglitazone, the go-to therapy
Many drugs have CV benefits, reduce HA1c, have metabolic effects, and improve NASH/NAFLD in people with diabetes. Still, pioglitazone, an SGLT2 inhibitor, seems to be one of the cheap drugs and has many functions with more significant benefits than risk. There are a lot of CV trials conducted like the …
Read More »Diabetes Technology in T1D Youth & Pediatrics Used for Glucose Control and Obesity
In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy. Many health complications can arise from diabetes, especially for adolescents and children with type 1 diabetes, …
Read More »Diabetic Ketoacidosis or Cannabis Related Hyperglycemic Ketosis in patient with Type 1 Diabetes
A retrograde cohort study suggests that metabolic and acid base parameters may be useful in differentiating typical diabetic ketoacidosis DKA from Hyperglycemic Ketoacidosis related to cannabis hyperemesis syndrome in patients with type 1 Diabetes After the legalization of cannabis in Colorado and increasing its use among patients with type 1 …
Read More »Physical Activity: a Cheaper and Better Way to Save Lives in Patients with Diabetes
Effective preventive strategies are needed to reduce cardiovascular disease, the leading cause of mortality and morbidity globally.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.